Byron Nash Renal Medullary Carcinoma Awareness Act of 2023

United States119th CongressHR-124House of Representatives
Updated: Jan 3, 2025

Summary

This bill aims to enhance awareness of renal medullary carcinoma (RMC) among individuals with sickle cell disease who are enrolled in Medicaid . It seeks to achieve this by providing financial incentives to states for offering educational services related to RMC risk. Specifically, the legislation amends Section 1903(a)(3)(E)(ii) of the Social Security Act, which governs federal medical assistance percentages. By inserting "renal medullary carcinoma" into the existing text, the bill ensures that states can receive enhanced federal matching funds for expenditures related to educating Medicaid beneficiaries with sickle cell disease about the risks of RMC. This change is intended to promote early detection and improved health outcomes for this vulnerable population.

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

  1. Introduced in House

  2. Referred to the House Committee on Energy and Commerce.

    House of Representatives

All available records shown.